Click for best price
Live Attenuated Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 26690 million
|
Forecast Market size by 2029 |
US$ 39700 million
|
| Growth Rate |
CAGR of 5.8% |
Number of Pages |
78 Pages |
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccines. This report contains market size and forecasts of Live Attenuated Vaccines in global, including the following market information:
Global Live Attenuated Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Live Attenuated Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Live Attenuated Vaccines companies in 2022 (%)
The global Live Attenuated Vaccines market was valued at US$ 26690 million in 2022 and is projected to reach US$ 39700 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
We surveyed the Live Attenuated Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines Market Segment Percentages, by Type, 2022 (%)
Bacterial
Viral
Global Live Attenuated Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Institutes
Others
Global Live Attenuated Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Vaccines revenues share in global market, 2022 (%)
Key companies Live Attenuated Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live Attenuated Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Attenuated Vaccines, market overview.
Chapter 2: Global Live Attenuated Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Live Attenuated Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Attenuated Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live Attenuated Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Live Attenuated Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 26690 million
|
| Forecast Market size by 2029 |
US$ 39700 million
|
| Growth Rate |
CAGR of 5.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Live Attenuated Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Attenuated Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Attenuated Vaccines Overall Market Size
2.1 Global Live Attenuated Vaccines Market Size: 2022 VS 2029
2.2 Global Live Attenuated Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Live Attenuated Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Live Attenuated Vaccines Players in Global Market
3.2 Top Global Live Attenuated Vaccines Companies Ranked by Revenue
3.3 Global Live Attenuated Vaccines Revenue by Companies
3.4 Global Live Attenuated Vaccines Sales by Companies
3.5 Global Live Attenuated Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Attenuated Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Attenuated Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Attenuated Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Live Attenuated Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Attenuated Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Attenuated Vaccines Market Size Markets, 2022 & 2029
4.1.2 Bacterial
4.1.3 Viral
4.2 By Type - Global Live Attenuated Vaccines Revenue & Forecasts
4.2.1 By Type - Global Live Attenuated Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Live Attenuated Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Live Attenuated Vaccines Sales & Forecasts
4.3.1 By Type - Global Live Attenuated Vaccines Sales, 2018-2023
4.3.2 By Type - Global Live Attenuated Vaccines Sales, 2024-2029
4.3.3 By Type - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Live Attenuated Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Attenuated Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application - Global Live Attenuated Vaccines Revenue & Forecasts
5.2.1 By Application - Global Live Attenuated Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Live Attenuated Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Live Attenuated Vaccines Sales & Forecasts
5.3.1 By Application - Global Live Attenuated Vaccines Sales, 2018-2023
5.3.2 By Application - Global Live Attenuated Vaccines Sales, 2024-2029
5.3.3 By Application - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Live Attenuated Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Live Attenuated Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Live Attenuated Vaccines Revenue & Forecasts
6.2.1 By Region - Global Live Attenuated Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Live Attenuated Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Live Attenuated Vaccines Sales & Forecasts
6.3.1 By Region - Global Live Attenuated Vaccines Sales, 2018-2023
6.3.2 By Region - Global Live Attenuated Vaccines Sales, 2024-2029
6.3.3 By Region - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Live Attenuated Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Live Attenuated Vaccines Sales, 2018-2029
6.4.3 US Live Attenuated Vaccines Market Size, 2018-2029
6.4.4 Canada Live Attenuated Vaccines Market Size, 2018-2029
6.4.5 Mexico Live Attenuated Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Live Attenuated Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Live Attenuated Vaccines Sales, 2018-2029
6.5.3 Germany Live Attenuated Vaccines Market Size, 2018-2029
6.5.4 France Live Attenuated Vaccines Market Size, 2018-2029
6.5.5 U.K. Live Attenuated Vaccines Market Size, 2018-2029
6.5.6 Italy Live Attenuated Vaccines Market Size, 2018-2029
6.5.7 Russia Live Attenuated Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Live Attenuated Vaccines Market Size, 2018-2029
6.5.9 Benelux Live Attenuated Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Live Attenuated Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Live Attenuated Vaccines Sales, 2018-2029
6.6.3 China Live Attenuated Vaccines Market Size, 2018-2029
6.6.4 Japan Live Attenuated Vaccines Market Size, 2018-2029
6.6.5 South Korea Live Attenuated Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Live Attenuated Vaccines Market Size, 2018-2029
6.6.7 India Live Attenuated Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Live Attenuated Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Live Attenuated Vaccines Sales, 2018-2029
6.7.3 Brazil Live Attenuated Vaccines Market Size, 2018-2029
6.7.4 Argentina Live Attenuated Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Attenuated Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Live Attenuated Vaccines Sales, 2018-2029
6.8.3 Turkey Live Attenuated Vaccines Market Size, 2018-2029
6.8.4 Israel Live Attenuated Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Live Attenuated Vaccines Market Size, 2018-2029
6.8.6 UAE Live Attenuated Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Live Attenuated Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Live Attenuated Vaccines Major Product Offerings
7.2.4 Merck Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Live Attenuated Vaccines Major Product Offerings
7.3.4 Pfizer Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Summary
7.4.2 Astellas Pharma Business Overview
7.4.3 Astellas Pharma Live Attenuated Vaccines Major Product Offerings
7.4.4 Astellas Pharma Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharma Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Live Attenuated Vaccines Major Product Offerings
7.5.4 Johnson & Johnson Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 CSL
7.6.1 CSL Company Summary
7.6.2 CSL Business Overview
7.6.3 CSL Live Attenuated Vaccines Major Product Offerings
7.6.4 CSL Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 CSL Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Live Attenuated Vaccines Major Product Offerings
7.7.4 Sanofi Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Serum Institute Of India
7.8.1 Serum Institute Of India Company Summary
7.8.2 Serum Institute Of India Business Overview
7.8.3 Serum Institute Of India Live Attenuated Vaccines Major Product Offerings
7.8.4 Serum Institute Of India Live Attenuated Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Serum Institute Of India Key News & Latest Developments
8 Global Live Attenuated Vaccines Production Capacity, Analysis
8.1 Global Live Attenuated Vaccines Production Capacity, 2018-2029
8.2 Live Attenuated Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Attenuated Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Attenuated Vaccines Supply Chain Analysis
10.1 Live Attenuated Vaccines Industry Value Chain
10.2 Live Attenuated Vaccines Upstream Market
10.3 Live Attenuated Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Attenuated Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Live Attenuated Vaccines in Global Market
Table 2. Top Live Attenuated Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Live Attenuated Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Live Attenuated Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Live Attenuated Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Live Attenuated Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Live Attenuated Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Live Attenuated Vaccines Product Type
Table 9. List of Global Tier 1 Live Attenuated Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live Attenuated Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Live Attenuated Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Live Attenuated Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Live Attenuated Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Live Attenuated Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Live Attenuated Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Live Attenuated Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Live Attenuated Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Live Attenuated Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Live Attenuated Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Live Attenuated Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Live Attenuated Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Live Attenuated Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Live Attenuated Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Live Attenuated Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Live Attenuated Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Live Attenuated Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Live Attenuated Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Live Attenuated Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Live Attenuated Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Live Attenuated Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Live Attenuated Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Live Attenuated Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Live Attenuated Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Live Attenuated Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Live Attenuated Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Live Attenuated Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Live Attenuated Vaccines Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Live Attenuated Vaccines Product Offerings
Table 48. GlaxoSmithKline Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Live Attenuated Vaccines Product Offerings
Table 52. Merck Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Live Attenuated Vaccines Product Offerings
Table 56. Pfizer Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Astellas Pharma Company Summary
Table 59. Astellas Pharma Live Attenuated Vaccines Product Offerings
Table 60. Astellas Pharma Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Astellas Pharma Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Live Attenuated Vaccines Product Offerings
Table 64. Johnson & Johnson Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. CSL Company Summary
Table 67. CSL Live Attenuated Vaccines Product Offerings
Table 68. CSL Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. CSL Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Live Attenuated Vaccines Product Offerings
Table 72. Sanofi Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Serum Institute Of India Company Summary
Table 75. Serum Institute Of India Live Attenuated Vaccines Product Offerings
Table 76. Serum Institute Of India Live Attenuated Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Serum Institute Of India Key News & Latest Developments
Table 78. Live Attenuated Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Live Attenuated Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Live Attenuated Vaccines Production by Region, 2018-2023 (K Units)
Table 81. Global Live Attenuated Vaccines Production by Region, 2024-2029 (K Units)
Table 82. Live Attenuated Vaccines Market Opportunities & Trends in Global Market
Table 83. Live Attenuated Vaccines Market Drivers in Global Market
Table 84. Live Attenuated Vaccines Market Restraints in Global Market
Table 85. Live Attenuated Vaccines Raw Materials
Table 86. Live Attenuated Vaccines Raw Materials Suppliers in Global Market
Table 87. Typical Live Attenuated Vaccines Downstream
Table 88. Live Attenuated Vaccines Downstream Clients in Global Market
Table 89. Live Attenuated Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Live Attenuated Vaccines Segment by Type in 2022
Figure 2. Live Attenuated Vaccines Segment by Application in 2022
Figure 3. Global Live Attenuated Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Live Attenuated Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Live Attenuated Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Live Attenuated Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Live Attenuated Vaccines Revenue in 2022
Figure 9. By Type - Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Live Attenuated Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Live Attenuated Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Live Attenuated Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Live Attenuated Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 23. US Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 37. China Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Live Attenuated Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Live Attenuated Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Live Attenuated Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Live Attenuated Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Live Attenuated Vaccines by Region, 2022 VS 2029
Figure 54. Live Attenuated Vaccines Industry Value Chain
Figure 55. Marketing Channels
